KM

Kalpeshkumar Maheshbhai Bhatt

Active Director Director DIN 10102312
DIN 10102312 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Kalpeshkumar Maheshbhai Bhatt

Data last updated:

Kalpeshkumar Maheshbhai Bhatt is a Director at Cordial Pharmaceutical Private Limited (since 2023). The company operates in Pharma. Cordial Pharmaceutical Private Limited reported revenue of ₹1 Lakh (FY 2022).

DIN 10102312
Primary Designation Director
Industry Pharma
First Appointment 20 Apr 2023
Oldest Company Age 5 yrs
Largest company Cordial Pharmaceutical Private Limited · ₹1 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Apr 20232021₹1 Lakh (FY 2022)Active

Board colleagues of Kalpeshkumar Maheshbhai Bhatt

Directorship timeline

Open interactive timeline →
Cordial Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Kalpeshkumar Maheshbhai Bhatt

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalpeshkumar Maheshbhai Bhatt

Kalpeshkumar Maheshbhai Bhatt currently holds 1 directorship: Cordial Pharmaceutical Private Limited (Director, since 20 Apr 2023, revenue ₹1 Lakh (FY 2022)).

Kalpeshkumar Maheshbhai Bhatt was first appointed on 20 Apr 2023 as Director at Cordial Pharmaceutical Private Limited.

The current boards of Kalpeshkumar Maheshbhai Bhatt's companies include Vishalbhai Karmanbhai Jograna (Cordial Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available